Tags

Type your tag names separated by a space and hit enter

Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs.
Int J Pharm. 2010 Sep 15; 397(1-2):225-30.IJ

Abstract

To develop a novel sibutramine base-loaded solid dispersion with enhanced solubility and bioavailability, various solid dispersions were prepared using a spray drying technique with hydrophilic polymers such as gelatin, HPMC and citric acid. Their solubility, thermal characteristics and crystallinity were investigated. The dissolution and pharmacokinetics of the sibutramine base-loaded solid dispersion were then compared with a sibutramine hydrochloride monohydrate-loaded commercial product (Reductil). The solid dispersions prepared with gelatin gave higher drug solubility than those prepared without gelatin, irrespective of the amount of polymer. The sibutramine base-loaded solid dispersions containing hydrophilic polymer and citric acid showed higher drug solubility compared to sibutramine base and sibutramine hydrochloride monohydrate. Among the formulations tested, the solid dispersion composed of sibutramine base/gelatin/HPMC/citric acid at the weight ratio of 1/0.8/0.2/0.5 gave the highest solubility of 5.03+/-0.24 mg/ml. Our DSC and powder X-ray diffraction results showed that the drug was present in an altered amorphous form in this solid dispersion. The difference factor (f(1)) values between solid dispersion and commercial product were 2.82, 6.65 and 6.31 at pH 1.2, 4.0 and 6.8, respectively. Furthermore, they had the similarity factor (f(2)) value of 65.68, 53.43 and 58.97 at pH 1.2, 4.0 and 6.8, respectively. Our results suggested that the solid dispersion and commercial product produced a similar correlation of dissolution profiles at all pH ranges. The AUC, C(max) and T(max) of the parent drug and metabolite I and II from the solid dispersion were not significantly different from those of the commercial product, suggesting that the solid dispersion might be bioequivalent to the commercial product in beagle dogs. Thus, the sibutramine base-loaded solid dispersion prepared with gelatin, HPMC and citric acid is a promising candidate for improving the solubility and bioavailability of the poorly water-soluble sibutramine base.

Authors+Show Affiliations

College of Pharmacy, Yeungnam University, 214-1, Dae-Dong, Gyongsan 712-749, South Korea.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20637849

Citation

Lim, Hyun-Tae, et al. "Development of Novel Sibutramine Base-loaded Solid Dispersion With Gelatin and HPMC: Physicochemical Characterization and Pharmacokinetics in Beagle Dogs." International Journal of Pharmaceutics, vol. 397, no. 1-2, 2010, pp. 225-30.
Lim HT, Balakrishnan P, Oh DH, et al. Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. Int J Pharm. 2010;397(1-2):225-30.
Lim, H. T., Balakrishnan, P., Oh, D. H., Joe, K. H., Kim, Y. R., Hwang, D. H., Lee, Y. B., Yong, C. S., & Choi, H. G. (2010). Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. International Journal of Pharmaceutics, 397(1-2), 225-30. https://doi.org/10.1016/j.ijpharm.2010.07.013
Lim HT, et al. Development of Novel Sibutramine Base-loaded Solid Dispersion With Gelatin and HPMC: Physicochemical Characterization and Pharmacokinetics in Beagle Dogs. Int J Pharm. 2010 Sep 15;397(1-2):225-30. PubMed PMID: 20637849.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. AU - Lim,Hyun-Tae, AU - Balakrishnan,Prabagar, AU - Oh,Dong Hoon, AU - Joe,Kwan Hyung, AU - Kim,Young Ran, AU - Hwang,Doo Hyung, AU - Lee,Yong-Bok, AU - Yong,Chul Soon, AU - Choi,Han-Gon, Y1 - 2010/07/15/ PY - 2010/05/05/received PY - 2010/06/29/revised PY - 2010/07/08/accepted PY - 2010/7/20/entrez PY - 2010/7/20/pubmed PY - 2011/2/8/medline SP - 225 EP - 30 JF - International journal of pharmaceutics JO - Int J Pharm VL - 397 IS - 1-2 N2 - To develop a novel sibutramine base-loaded solid dispersion with enhanced solubility and bioavailability, various solid dispersions were prepared using a spray drying technique with hydrophilic polymers such as gelatin, HPMC and citric acid. Their solubility, thermal characteristics and crystallinity were investigated. The dissolution and pharmacokinetics of the sibutramine base-loaded solid dispersion were then compared with a sibutramine hydrochloride monohydrate-loaded commercial product (Reductil). The solid dispersions prepared with gelatin gave higher drug solubility than those prepared without gelatin, irrespective of the amount of polymer. The sibutramine base-loaded solid dispersions containing hydrophilic polymer and citric acid showed higher drug solubility compared to sibutramine base and sibutramine hydrochloride monohydrate. Among the formulations tested, the solid dispersion composed of sibutramine base/gelatin/HPMC/citric acid at the weight ratio of 1/0.8/0.2/0.5 gave the highest solubility of 5.03+/-0.24 mg/ml. Our DSC and powder X-ray diffraction results showed that the drug was present in an altered amorphous form in this solid dispersion. The difference factor (f(1)) values between solid dispersion and commercial product were 2.82, 6.65 and 6.31 at pH 1.2, 4.0 and 6.8, respectively. Furthermore, they had the similarity factor (f(2)) value of 65.68, 53.43 and 58.97 at pH 1.2, 4.0 and 6.8, respectively. Our results suggested that the solid dispersion and commercial product produced a similar correlation of dissolution profiles at all pH ranges. The AUC, C(max) and T(max) of the parent drug and metabolite I and II from the solid dispersion were not significantly different from those of the commercial product, suggesting that the solid dispersion might be bioequivalent to the commercial product in beagle dogs. Thus, the sibutramine base-loaded solid dispersion prepared with gelatin, HPMC and citric acid is a promising candidate for improving the solubility and bioavailability of the poorly water-soluble sibutramine base. SN - 1873-3476 UR - https://www.unboundmedicine.com/medline/citation/20637849/Development_of_novel_sibutramine_base_loaded_solid_dispersion_with_gelatin_and_HPMC:_physicochemical_characterization_and_pharmacokinetics_in_beagle_dogs_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5173(10)00523-5 DB - PRIME DP - Unbound Medicine ER -